Protara Therapeutics, Inc.

Rachunek Zysków i Strat





Przychody TTM (mln): 1
EBIT TTM (mln): -46
index 0 1 2 3 4 5 6 7 8 9 10 11 12
Rok finansowy 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 3 0 0 0 0 0 0 0 0 0 0
Przychód Δ r/r 0.0% 0.0% inf% -100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Marża brutto -inf% -inf% 100.0% 0.0% 0.0% 0.0% 0.0% -inf% -inf% -inf% -inf% -inf% 0.0%
EBIT (mln) -8 -7 -8 -21 -29 -30 -26 -15 -34 -47 -67 -44 -49
EBIT Δ r/r 0.0% -10.9% 6.4% 175.3% 37.5% 5.8% -14.1% -41.5% 125.8% 37.9% 41.2% -35.0% 12.7%
EBIT (%) 0.0% 0.0% -257.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Koszty finansowe (mln) 0 1 1 0 0 0 0 0 0 2 1 0 4
EBITDA (mln) -8 -7 -2 -21 -28 -30 -26 -15 -34 -47 -8 -43 -49
EBITDA(%) 0.0% 0.0% -83.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Podatek (mln) 0 0 5 -0 0 1 5 -0 -0 -0 -1 -0 0
Zysk Netto (mln) -8 -8 -3 -21 -29 -30 -25 -15 -34 -47 -65 -40 -45
Zysk netto Δ r/r 0.0% -0.7% -57.8% 539.6% 33.4% 5.0% -15.1% -42.1% 127.5% 40.7% 37.5% -37.6% 10.3%
Zysk netto (%) 0.0% 0.0% -113.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
EPS -37.62 -37.43 -43.62 -51.94 -68.9 -69.38 -9.93 -228.6 -4.63 -4.2 -5.76 -3.57 -2.17
EPS (rozwodnione) -37.62 -37.43 -43.62 -51.94 -68.9 -69.38 -9.93 -228.6 -4.63 -4.2 -5.76 -3.57 -2.17
Ilośc akcji (mln) 0 0 0 0 0 0 3 0 7 11 11 11 21
Ważona ilośc akcji (mln) 0 0 0 0 0 0 3 0 7 11 11 11 21
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD